Nora Pharmaceuticals Closes On $25 Million
Friday, October 24, 2008 5:57:00 AM PDT | VentureDeal Staff
United States -- Pharmaceutical company Nora Pharmaceuticals (no website) has secured $25 million its first round of venture capital funding, according to a report in PE Hub.
Nora is in stealth mode, but is believed to be developing products for the womens reproductive health market.
Burrill & Co. led the round, which also included Prospect Venture Partners and Vivo Ventures. Proceeds purposes from the funding was not disclosed.
Email Page | Print Page